Prostatic Acid Phosphatase (PAP) is an enzyme primarily produced by the prostate gland, historically significant as a tumor marker for prostate cancer. Although its role in screening has diminished with the advent of prostate-specific antigen (PSA) testing, PAP remains useful in specific clinical scenarios. It can provide prognostic information for predicting recurrence after radical prostatectomy and monitoring treatment responses, particularly in cases where PSA results are inconclusive. However, elevated PAP levels can also result from benign conditions like benign prostatic hyperplasia or prostatic infarction, complicating interpretation. The test involves an automated chemiluminescent immunometric assay, requiring careful specimen collection and processing to ensure accuracy. While PAP offers supplementary insights, it should be interpreted alongside other diagnostic tools due to its limited specificity. Despite its reduced role in routine screening, PAP continues to be a valuable adjunct in managing prostate cancer, offering unique insights in certain clinical contexts.
Prostatic Acid Phosphatase (PAP) is an enzyme primarily produced by the prostate gland, historically significant as a tumor marker for prostate cancer. Although its role in screening has diminished with the advent of prostate-specific antigen (PSA) testing, PAP remains useful in specific clinical scenarios. It can provide prognostic information for predicting recurrence after radical prostatectomy and monitoring treatment responses, particularly in cases where PSA results are inconclusive. However, elevated PAP levels can also result from benign conditions like benign prostatic hyperplasia or prostatic infarction, complicating interpretation. The test involves an automated chemiluminescent immunometric assay, requiring careful specimen collection and processing to ensure accuracy. While PAP offers supplementary insights, it should be interpreted alongside other diagnostic tools due to its limited specificity. Despite its reduced role in routine screening, PAP continues to be a valuable adjunct in managing prostate cancer, offering unique insights in certain clinical contexts.
The lowest price from the last 30 days: £55
Awaiting result:
One day
Collect material:
Blood
Prepare:
Prostatic acid phosphatase (PAP) is a glycoprotein enzyme primarily produced by the prostate gland. Historically significant as a tumor marker for prostate cancer, its role has diminished with the advent of PSA testing. However, PAP remains useful in specific scenarios:
- Predicting recurrence post-radical prostatectomy
- Monitoring treatment response, especially in androgen ablation therapy
Limitations include:
- Elevated levels due to benign conditions
- Interference from antibodies
Specimen handling is crucial, requiring immediate freezing for stability. PAP levels should be interpreted alongside other diagnostic tools, offering supplementary insights in prostate cancer management.
Prostatic acid phosphatase (PAP) testing is primarily relevant for specific clinical scenarios in prostate cancer management. Key considerations include:
- Predicting Recurrence: Useful after radical prostatectomy to assess recurrence risk.
- Monitoring Treatment: Offers supplementary insights during androgen ablation therapy, especially when PSA levels are inconclusive.
- Limitations: Elevated PAP can result from non-cancerous conditions like benign prostatic hyperplasia, complicating interpretation.
- Specimen Handling: Requires careful collection and freezing to ensure accuracy.
While not suitable for routine screening, PAP can provide valuable prognostic information when used alongside other diagnostic tools.
Understanding test results for Prostatic Acid Phosphatase (PAP) involves recognizing its role and limitations in prostate health diagnostics. Here are key points to consider:
- Historical Context: Once a primary marker for prostate cancer, PAP's role has diminished with the advent of PSA testing.
- Current Use: Primarily used for predicting recurrence post-prostatectomy and monitoring treatment, especially when PSA results are inconclusive.
- Limitations: Elevated PAP can result from non-cancerous conditions, complicating interpretation.
- Specimen Handling: Proper collection and storage are crucial for accurate results.
- Clinical Interpretation: PAP should be used alongside other diagnostic tools for comprehensive assessment.
The lowest price from the last 30 days: £55
What is GetLabTest.com?
How do I get started with GetLabTest.com?
What diseases can GetLabTest.com detect?
How do I prepare for testing with GetLabTest.com?
Can I speak with a doctor about my results?
Is testing with GetLabTest.com covered by insurance?
How long does it take to receive the test results?
Can I access my test results online?
Is my personal information kept confidential?
What if I have questions or concerns about my test results?